The biotech sector saw significant gains following FDA approvals and promising clinical trial progress. Notably, Novo Nordisk's Wegovy pill received approval for weight management and cardiovascular protection, boosting its stock. Positive trends also emerged for IDEAYA Biosciences, Neumora Therapeutics, and other companies, highlighting strong investor sentiment in the sector.